Latest From Biotech Now

BIO Delivers Keynote at the DoE’s Bioenergy 2016!

EricksonBrent_BTN

The U.S. Department of Energy’s Bioenergy Technologies Office held its ninth annual “Bioenergy 2016: Mobilizing the Bioeconomy through Innovation” conference from July 12-14, 2016 in Washington, D.C. This year’s conference focused on opportunities to grow future feedstock supplies and break through technology barriers in order to achieve a stronger bioeconomy. Several topics that were addressed during programming included looking at innovative and emerging pathways; forecasting feedstocks; marketplace exploration; and strategic public engagement. On Wednesday July 13, 2016, Brent Erickson, BIO’s Executive Vice Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Conference on Clinical Research for Rare Diseases on November 3rd

RDCRN_CCRRD_Conference_November_3_2016

BIO members may be interested in the upcoming Conference on Clinical Research for Rare Diseases, hosted by the Rare Diseases Clinical Research Network.  The Rare Diseases Clinical Research Network is an initiative of the Office of Rare Diseases Research, NCATS, funded through a collaboration between NCATS and the NIH.  The conference will be held on November 3, 2016 at the Washington Marriott Wardman Park. There are more than 6,800 diseases classified as “rare” (defined as Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Applauds House Passage of the Fostering Innovation Act

scientist, lab

The House of Representatives has overwhelmingly passed the Fostering Innovation Act (H.R. 4139), a key capital markets priority for BIO. The bipartisan legislation was introduced by Reps. Kyrsten Sinema (D-AZ) and Michael Fitzpatrick (R-PA). The JOBS Act provides emerging growth companies (EGCs) with a five-year exemption from Section 404(b) of Sarbanes-Oxley (SOX), which requires a costly external attestation of a company’s internal financial controls. The Fostering Innovation Act would extend the JOBS Act’s SOX 404(b) Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

8 Reasons New Medicines are Needed for Alzheimer’s

synthetic biology

Last week, the Alzheimer’s Association released an infographic with eight mythbusting facts to help dispel common misconceptions about the disease when it comes to prevention, financial impact, symptoms, and other areas. As the infographic confirms, there is no cure for this irreversible neurological disease, and only half of people living with Alzheimer’s (the 6th leading cause of death in the US) have actually been diagnosed. PhRMA’s report on Medicines in Development for Alzheimer’s Disease notes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

A Sheep Named Dolly – A Look at the First Cloned Animal Twenty Years Later!

Dolly_sheep

On July 5, 1996, scientists at Scotland’s Roslin Institute announced that they had successfully cloned the first animal from an adult cell — a sheep named Dolly. Dolly was the first mammal to be successfully cloned using somatic cell nuclear transfer (SCNT) technology. This technique makes it possible to produce multiple animals from a single donor, and involves transferring the genetic information from a cell from the body of an animal into an empty oocyte, or egg. Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , ,